Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 33NETWORK 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13Glioblastoma 10Glioma 7Astrocytoma 6Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Neoplasms 4Brain Neoplasms 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Stomach Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Oligodendroglioma 2Melanoma 2Carcinoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Seroma 1Rectal Neoplasms 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Patient Preference 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Inflammatory Breast Neoplasms 1

Interventions

Bevacizumab 188Fluorouracil 150Leucovorin 134Cetuximab 127Irinotecan 114Oxaliplatin 108pembrolizumab 96Capecitabine 82IFL protocol 53Panitumumab 43regorafenib 42Nivolumab 42Folfox protocol 40Gemcitabine 30trifluridine tipiracil drug combination 27Cisplatin 24Carboplatin 24atezolizumab 22Pemetrexed 20Paclitaxel 20Drug Therapy 20130-nm albumin-bound paclitaxel 17Trastuzumab 14encorafenib 13Trifluridine 13Ipilimumab 13HMPL-013 13tislelizumab 12spartalizumab 11Docetaxel 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Colorectal Neoplasms × Surgical Procedures, Operative × Clear all
NCT00152230 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
900 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡